🇺🇸 Acetaminophen PO in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 21 April 2025 – 21 April 2026
- Total reports: 11
Most-reported reactions
- Urticaria — 2 reports (18.18%)
- Abdominal Distension — 1 report (9.09%)
- Alanine Aminotransferase Increased — 1 report (9.09%)
- Aspartate Aminotransferase Increased — 1 report (9.09%)
- Blood Cholesterol Increased — 1 report (9.09%)
- Blood Triglycerides Increased — 1 report (9.09%)
- Erythema — 1 report (9.09%)
- Eye Swelling — 1 report (9.09%)
- Haemolysis — 1 report (9.09%)
- Hypoxia — 1 report (9.09%)
Other Pain Management approved in United States
Frequently asked questions
Is Acetaminophen PO approved in United States?
Acetaminophen PO does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Acetaminophen PO in United States?
The University of Texas Health Science Center, Houston is the originator. The local marketing authorisation holder may differ — check the official source linked above.